Formal Consensus Method to Evaluate the Conformity of Prescription of a Recently Approved Chemotherapy Treatment in an Observatory Study

Cabazitaxel is a second line chemotherapy drug recently approved for the treatment of metastatic castration-resistant prostate cancer. A first panel of French experts and a second independent panel of European experts were convened to assess the conformity of prescription of cabazitaxel with a Delph...

Descripción completa

Detalles Bibliográficos
Autores principales: Houédé, Nadine, Leutenegger, Eric, Lomma, Mariella, Bellera, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383448/
https://www.ncbi.nlm.nih.gov/pubmed/25837603
http://dx.doi.org/10.1371/journal.pone.0123035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383448/
https://www.ncbi.nlm.nih.gov/pubmed/25837603
http://dx.doi.org/10.1371/journal.pone.0123035

Ejemplares similares